Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials
NHS hospitals in England used £16,495,950 of indicative cost of Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 1.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Turoctocog alfa pegol 3,000unit powder and solvent for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £10,207,650 |
| Sheffield Teaching Hospitals Nhs Trust | £3,108,450 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,259,700 |
| University Hpls Of Leicester Nhs Trust | £673,200 |
| United Lincolnshire Hospitals Nhs Trust | £334,050 |
| York Teaching Hospital Nhs Ft | £306,000 |
| Alder Hey Childrens Nhs Foundation Trust | £173,400 |
| Derby Teaching Hospitals Nhs Found Trust | £153,000 |
| Univ Hpl B/Ham Nhs Foundation Trust | £122,400 |
| University Hospitals Dorset Nhs Ft | £81,600 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.